Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.
about
The Gut Microbiota in Immune-Mediated Inflammatory DiseasesThe role of the microbiome in rheumatic diseasesMetalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.Microbial Infection and Rheumatoid Arthritis.Angiogenesis in rheumatoid arthritis.Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells.Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritisAdvances in the treatment of rheumatoid arthritis: old versus new therapies.Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis.Metalloproteinases: their role in arthritis and potential as therapeutic targets.Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis.Rheumatoid arthritis. Targeted interventions can minimize joint destruction.Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trialMinocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.Use of macrolides and tetracyclines for chronic inflammatory diseases.Infliximab for the treatment of early rheumatoid arthritis.Minocycline for short-term neuroprotectionMast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy.Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.Antibiotics for the treatment of rheumatoid arthritis.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.An update on drug-induced arthritis.Minocycline: Rheumatoid Arthritis.Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine.Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study.
P2860
Q26741414-189ABB84-ECB9-4FC3-BE6B-FBDFD4A712CFQ28284835-770CF9BF-248C-44C4-9E2C-6DCCA4CF66C8Q33660754-5F8DEE65-D396-412C-8D53-61592A9F8674Q34040402-9F008404-4089-48E2-9F85-9840CBD59403Q34051829-0743C735-561E-473F-94D3-9222854C7FA8Q34102337-8DC09CC3-B793-4913-A154-93A74939711EQ34290839-386455E4-5404-4CF4-AFC2-3D3FE5209566Q34706876-F1421D3F-9C05-4126-9A1F-EB8CE9920964Q34707761-FF0D82AD-E91F-424B-B995-903C5EBBDF8AQ35056019-C93BAF49-1D45-45A9-8119-5A4E48FD57AFQ35098842-395C7828-0422-48C5-8B61-3DF0220DF9EEQ35597974-9D89AD1B-900D-4F86-A471-A42018D5B8ACQ35789318-37561054-9F61-475F-A767-FE8B73A0362EQ35840805-057BA80B-AEF6-483A-B82F-7DF1800F1D5BQ35962028-97B775DF-A63C-4B60-8C4D-F2565A0C80DEQ36099482-509B71BD-6C4E-48AF-AA9B-52A8AFB722EFQ36428406-3D55B30B-FA88-4D6C-9ED5-4837BEF70B1DQ36819873-06955829-D449-4064-8924-A74D09CCC285Q37356818-E1E4EA2E-FE5B-4922-8C0A-05C2EFC98CB9Q38176897-41C87466-48E8-4C2F-ADB5-68788E7A3CB2Q38561490-E4874F24-18F8-4948-B638-39A968019C58Q38616743-00633895-A9D6-412E-9BFF-2BE34671E279Q38783509-5DD34577-3AA8-49E2-A134-85E12B5856D6Q42363979-CD7566AD-7C94-405D-9A24-23E0024C8F59Q43219125-4E529D2C-EB18-4E23-8598-1C9C0D10DDBCQ46470525-7FB1D02C-B187-4810-8363-92D39D8C613AQ52854066-EC40DB68-BB30-405E-A6DA-6F3B73D3D49F
P2860
Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Treatment of early seropositiv ...... ycline and hydroxychloroquine.
@en
type
label
Treatment of early seropositiv ...... ycline and hydroxychloroquine.
@en
prefLabel
Treatment of early seropositiv ...... ycline and hydroxychloroquine.
@en
P2093
P2860
P1476
Treatment of early seropositiv ...... ycline and hydroxychloroquine.
@en
P2093
Blakely KW
Eckhoff PJ
Fernandez AM
Klassen LW
P2860
P304
P356
10.1002/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A
P577
2001-10-01T00:00:00Z